Company intelligence / Profile preview

Altruix

Annapolis, Maryland, United Statesaltruix.com ↗

Ownership: Private
Development stage: Other

Overview

Terrapin Pharmacy—now operating as Altruix—provides closed-door specialty pharmacy services focused on improving medication adherence among patients with severe mental illness, substance use disorders, and intellectual/developmental disabilities. The company leverages proprietary technology such as the Medherent device to support real-time medication management in long-term care settings. It does not develop drugs but specializes in innovative delivery models for complex patient populations.

Therapeutic areas: PsychiatryNeurologyOther
Modalities: DeviceSmall molecule
Industry: Non-Academic Healthcare

Partnerships

Codeproof MDM for Medherent device management

Beyond the preview

Go deeper on Altruix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altruix.

Explore the full profile